By WSJ Staff
Novo Nordisk (NVO): The Food and Drug Administration approved Novo Nordisk's popular weight-loss drug Wegovy to treat a form of liver disease. Shares climbed roughly 4.5% in Denmark (read more about weight-loss drugs' surprise foe).
Soho House $(SHCO)$: Investors led by one of the U.S.'s biggest hotel owners are nearing a deal to take Soho House private, The Wall Street Journal reported. Shares in the members' club operator rose 13% in premarket trading.
UnitedHealth $(UNH)$: Shares gained 3% premarket, after leaping Friday following Berkshire Hathaway $(BRK.B)$'s disclosure that it had taken a stake in the embattled health insurer.
Grand Canyon Education $(LOPE)$: The Federal Trade Commission dismissed a Biden-era complaint that accused the education company of falsely claiming to be a nonprofit.
Palo Alto Networks (PANW): The cybersecurity company is set to publish quarterly results after the market close. It recently agreed to buy CyberArk Software $(CYBR)$ for $25 billion.
This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL (WSJ Live Coverage).
(END) Dow Jones Newswires
August 18, 2025 05:23 ET (09:23 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。